J2P-MC-LXBD

Medable Inc.
1+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image
Screenshot image

About this app

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain.
Updated on
Apr 3, 2024

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Personal info, Health and fitness and 2 others
Data is encrypted in transit

What's new

Bug fixes and improvements.
Flag as inappropriate

App support

More by Medable Inc.

AFX3772-003 Patient App
Medable Inc.
Option VMS
Medable Inc.
Medable Participant App
Medable Inc.
4.4
DS7300-188
Medable Inc.
Avanti
Medable Inc.
CHONQUER
Medable Inc.

Similar apps

Experience Nixa
Armstrong Software
Fisiaforma events
Teksmobile
Element Mortgage
APMobile
4.2
Flag as inappropriate